Hester Biosciences Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: HESTERBIO BSE: 524669

₹2105.50

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #81 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Hester Biosciences Limited (this stock)	1,791	30.4	15.6%	17.4%	0.52%	80	45	31

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹1,865 Cr

EV / EBITDA

18.7x

EV / Sales

6.19x

Market cap / Sales

5.94x

Earnings yield

3.29%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 74 Cr, up 15.4% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 15 Cr, up 87.7% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	73	20	15	₹17.2900
March 31, 2026	94	35	26	₹31.0100
Dec. 31, 2025	70	15	11	₹12.5400
Sept. 30, 2025	65	10	7	₹8.4800
June 30, 2025	63	10	8	₹9.2100
March 31, 2025	77	11	10	₹11.3300
Dec. 31, 2024	63	6	4	₹5.2200
Sept. 30, 2024	74	12	9	₹10.9700
June 30, 2024	73	11	8	₹9.9100
March 31, 2024	73	10	7	₹8.7400
Dec. 31, 2023	66	9	6	₹7.6100
Sept. 30, 2023	66	9	7	₹7.9700
June 30, 2023	80	9	6	₹7.6100

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	74	98	71	66	64	78	64	75	75	74	66	68	81
Operating revenue	73	94	70	65	63	77	63	74	73	73	66	66	80
Other income	2	4	1	1	1	1	1	1	1	1	1	1	1
Operating expenses	48	62	54	53	51	63	54	59	60	60	54	54	69
Operating profit	24	31	17	12	12	14	9	15	13	12	12	12	11
Operating profit margin	33.5%	33.6%	23.8%	18.4%	19.5%	17.9%	14.3%	20.0%	18.4%	17.0%	17.7%	18.1%	14.1%
Depreciation	5	4	2	2	2	2	2	2	2	2	3	3	3
Interest	1	4	1	1	1	1	2	1	1	1	1	1	1
Exceptional items, gain / (loss)	—	7	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	20	35	15	10	10	11	6	12	11	10	9	9	9
Tax	5	8	4	3	2	2	2	3	3	3	2	2	2
Net profit	15	26	11	7	8	10	4	9	8	7	6	7	6
EPS	17.29	31.01	12.54	8.48	9.21	11.33	5.22	10.97	9.91	8.74	7.61	7.97	7.61
Net profit (TTM)	59	52	35	29	31	32	30	32	29	27	26	30	34
EPS (TTM)	69.32	61.24	41.56	34.24	36.73	37.43	34.84	37.23	34.23	31.93	30.55	35.55	39.74

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	292	70	52
March 31, 2025	286	42	32
March 31, 2024	285	37	27
March 31, 2023	254	44	32

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	5.0%	7.4%	300^†	291^†	289^†	259^†	224^†	210^†	174^†	139^†	124^†
Operating revenue	4.8%	7.0%	292	286	285	254	219^†	208^†	171^†	137^†	123^†
Other income	—	—	8^†	5^†	4^†	5^†	5^†	2^†	3^†	2^†	1^†
Operating expenses	—	—	220^†	236^†	238^†	199^†	159^†	136^†	103^†	87^†	80^†
Operating profit	9.7%	0.1%	72^†	51^†	47^†	55^†	61^†	72^†	68^†	50^†	43^†
Operating profit margin	—	—	24.8%^†	17.8%^†	16.6%^†	21.6%^†	27.6%^†	34.5%^†	39.6%^†	36.2%^†	35.2%^†
Depreciation	—	—	10^†	9^†	10^†	10^†	10^†	10^†	8^†	5^†	6^†
Interest	—	—	7^†	5^†	5^†	6^†	2^†	4^†	4^†	2^†	3^†
Exceptional items, gain / (loss)	—	—	7^†	0^†	0^†	0^†	0^†	-5^†	0^†	0^†	0^†
Profit before tax	16.6%	4.9%	70	42	37	44	53^†	55^†	60^†	44^†	33^†
Tax	—	—	18^†	10^†	10^†	12^†	14^†	15^†	16^†	13^†	8^†
Net profit	17.2%	5.5%	52	32	27	32	40^†	40^†	44^†	31^†	25^†
EPS	17.2%	5.5%	61.24^†	37.43^†	31.93^†	38.01^†	—	46.89^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Operating margin	24.8%^†	17.8%^†	16.6%^†	21.6%^†	27.6%^†	34.5%^†	39.6%^†	36.2%^†	35.2%^†
EBIT margin	26.3%^†	16.5%^†	14.7%^†	19.9%^†	25.4%^†	28.2%^†	37.0%^†	33.6%^†	29.3%^†
PBT margin	23.9%	14.6%	12.9%	17.3%	24.3%^†	26.3%^†	34.9%^†	31.9%^†	26.7%^†
Net margin	17.8%	11.1%	9.5%	12.7%	18.0%^†	19.1%^†	25.6%^†	22.3%^†	20.2%^†
Interest coverage	10.72x^†	8.78x^†	8.21x^†	7.76x^†	22.58x^†	14.88x^†	17.86x^†	19.88x^†	11.27x^†
Dividend payout	11.4%^†	16.0%^†	25.1%^†	26.3%^†	—	14.1%^†	—	—	—
Earnings retention	88.6%^†	84.0%^†	74.9%^†	73.7%^†	—	85.9%^†	—	—	—
Current ratio	2.06x	1.92x	—	—	—	—	—	—	—
Quick ratio	1.41x	1.31x	—	—	—	—	—	—	—
Debt to equity	0.19x	0.31x	—	—	—	—	—	—	—
Return on equity	13.5%	9.4%	—	—	—	—	—	—	—
Return on assets	9.3%	5.8%	—	—	—	—	—	—	—
Return on capital employed	16.5%^†	10.5%^†	—	—	—	—	—	—	—
Asset turnover	0.52x	0.52x	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	51	-2	-48	17	34
March 31, 2025	64	-19	-46	21	43
March 31, 2024	43	-21	-24	22	20
March 31, 2023	33	-72	41	73	-39
March 31, 2022	16	-111	95	91	-75

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	557	385	377	53	22	190	92	1	288	60
March 31, 2025	546	339	331	53	51	185	97	1	105	59
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.